Liu Zhihua for China Daily writes (excerpted); The company has been developing an immune cell therapy product based on a method called Expanding Activated Lymphocytes to treat solid tumor, and the clinical trial is designed to access the therapy’s ability to...
A recent study looking at digital patient recruitment for clinical trials found that social media in particular offers significant upside when it comes to usability for trial education and ultimately, enrollment. The study, “Content That Clicks: Effective Social...
Asia-Pacific specialist CRO Novotech announced today that clinical staff numbers in its Seoul, South Korea centre are now at 41, with 81 clinical research projects now completed. The Novotech South Korea success is largely fueled by demand for a regional CRO with...
Clinical Trial Media, a global clinical trial patient recruitment and retention, today announced that Cara Brant has taken full ownership of the company and will become Clinical Trial Media’s chief executive officer, effective immediately. Brant, who began her career...
Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies designed to restore the body’s innate immune system, has enrolled 10 of the 20 patients with moderate to severe Crohn’s disease...
Email
Text